To hear about similar clinical trials, please enter your email below
Trial Title:
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
NCT ID:
NCT05582551
Condition:
Childhood Cancer
Conditions: Keywords:
childhood cancer survivors
electronic medical record
sensory deficit screening
hearing loss
peripheral neuropathy
vestibular
vision
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Highlighting Patients at Risk for Sensory Screening (HPARSS)
Description:
Collaborators in the Informatics Research branch of the Institute of Informatics at the
Washington University School of Medicine will identify CCS at risk for sensory deficits
based upon their therapy exposure to generate the HPARSS document.
Arm group label:
Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)
Summary:
The overall goal of this study is to attempt to overcome the organizational barriers that
impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS).
Using a cross sectional design study, collaborators in the Informatics Research branch of
the Institute of Informatics at the Washington University School of Medicine will
identify CCS at risk for sensory deficits based upon their therapy exposure to generate
the highlighting patients at risk for sensory screening (HPARSS) document. The
investigators will utilize the HPARSS that will link therapy related risks for sensory
deficits to specific screening procedures prompting the primary oncology provider to
implement screening, diagnostic testing, and therapy.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)
- Treatment including chemotherapy and/or radiation therapy
- Completion of all cancer therapy for at least 6 months and less than 2 years
- Followed in the Division of Pediatric Hematology/Oncology Program at the Washington
University School of Medicine
- Current age between 7 and 17 years of age (age where all of the screening tests are
both valid and have been successfully performed by our group)
- English speaking
Exclusion Criteria:
- Undergoing active cancer treatment
- Patient under the care of the Late Effects Program at St. Louis Children's Hospital
- Received previous diagnostic testing or rehabilitative therapy for a secondary
deficit eligible for screening.
- Parents and/or patient illiteracy
- No contact with treatment team in the past two years
- In foster care or without a legal guardian
Gender:
All
Minimum age:
7 Years
Maximum age:
17 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
St. Louis Children's Hospital - Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Robert J Hayashi, M.D.
Phone:
314-454-6018
Email:
hayashi_r@wustl.edu
Investigator:
Last name:
Robert J Hayashi, M.D.
Email:
Principal Investigator
Investigator:
Last name:
Ashley Housten, OTD, MSCI
Email:
Sub-Investigator
Investigator:
Last name:
Caroline Mohrmann, PNP, Ph.D.
Email:
Sub-Investigator
Investigator:
Last name:
Thomas Kannampallil, Ph.D.
Email:
Sub-Investigator
Investigator:
Last name:
Patrick Lyons, M.D., MSc
Email:
Sub-Investigator
Investigator:
Last name:
Susan Hayashi, MA
Email:
Sub-Investigator
Investigator:
Last name:
Belinda Sinks, AUD
Email:
Sub-Investigator
Investigator:
Last name:
Anna Perlmutter, OTR/L
Email:
Sub-Investigator
Investigator:
Last name:
Feng Gao, M.D., Ph.D., MPH, MS
Email:
Sub-Investigator
Start date:
August 2, 2023
Completion date:
May 31, 2025
Lead sponsor:
Agency:
Washington University School of Medicine
Agency class:
Other
Collaborator:
Agency:
St. Jude Children's Research Hospital
Agency class:
Other
Source:
Washington University School of Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05582551
http://www.siteman.wustl.edu
